GE VERNOVA INC
GEVNYSE🏆 #58 by market capEarnings Oct 28 · PreUS Equity
$878.03▼ $17.01 (−1.90%)
🌙 After hours$867.94▼ 1.15%Regular close · extended-hours price shownTrack GEV
Get earnings, price moves & breaking news on Telegram
24h▼ 1.9%
7d▼ 5.2%
14d▼ 6.8%
30d▼ 7.5%
ytd▲ 34.3%
1y▲ 53.9%
🏦Market Cap
$233.85B
Large Cap
📈Revenue Growth (YoY)
13.0%
Healthy
📊Gross Margin
20.3%
Moderate
💵FCF Margin
30.1%
Strong
⚖️P/S Ratio
5.2x
Fair
Otter Score
60
Fair
GE VERNOVA INC
GEVAnalyst Ratings
Price
$878.03
Total
29
Raised
2
Lowered
4
Avg PT
$1258.13
H / L
$1450 / $949
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Bernstein | Reiterated | Outperform | 2026-10-28 | $1298.00 | +47.80% |
Susquehanna | Reiterated | Positive | 2026-10-14 | $1270.00 | +44.60% |
Guggenheim | Reiterated | Buy | 2026-10-13 | $1450.00 | +65.10% |
JP Morgan | Reiterated | Overweight | 2026-10-09 | $330.00 | −62.40% |
Mizuho | Reiterated | Neutral | 2026-07-27 | — | — |
RBC Capital | Reiterated | Outperform | 2026-07-23 | $1225.00 | +39.50% |
Morgan Stanley | Reiterated | Overweight | 2026-07-23 | $817.00 | −7.00% |
TD Cowen | Reiterated | Buy | 2026-07-23 | — | — |
Oppenheimer | Reiterated | Outperform | 2026-07-23 | $1338.00 | +52.40% |
Jefferies | Reiterated | Buy | 2026-06-11 | $1185.00 | +35.00% |
BNP Paribas | Downgraded | Outperform → Neutral | 2026-04-27 | $1190.00 | +35.50% |
Barclays | Reiterated | Overweight | 2026-04-23 | $1250.00 | +42.40% |
Evercore ISI Group | Reiterated | Outperform | 2026-04-23 | — | — |
BMO Capital | Reiterated | Outperform | 2026-04-23 | $1250.00 | +42.40% |
Baird | Reiterated | Outperform | 2026-04-23 | — | — |
Citigroup | Reiterated | Neutral | 2026-04-13 | — | — |
Wells Fargo | Reiterated | Overweight | 2026-03-31 | $831.00 | −5.40% |
Rothschild & Co | Upgraded | Sell → Buy | 2026-03-09 | — | — |
Goldman Sachs | Reiterated | Buy | 2026-01-29 | $1328.00 | +51.20% |
GLJ Research | Reiterated | Buy | 2026-01-12 | $1087.00 | +23.80% |
Seaport Global | Downgraded | Buy → Neutral | 2025-12-11 | $723.00 | −17.70% |
B of A Securities | Reiterated | Buy | 2025-12-10 | — | — |
UBS | Reiterated | Buy | 2025-12-10 | $936.00 | +6.60% |
Melius Research | Upgraded | Hold → Buy | 2025-09-15 | $740.00 | −15.70% |
HSBC | Reiterated | Hold | 2025-09-05 | $255.00 | −71.00% |
Wolfe Research | Downgraded | Outperform → Peer Perform | 2025-06-13 | — | — |
Truist Securities | Reiterated | Buy | 2025-01-23 | — | — |
Daiwa Capital | Reiterated | Outperform → Buy | 2024-10-30 | — | — |
Raymond James | Downgraded | Outperform → Market Perform | 2024-10-02 | — | — |
Institution
Bernstein
Reiterated · Outperform · 2026-10-28
$1298.00
+47.80%
Susquehanna
Reiterated · Positive · 2026-10-14
$1270.00
+44.60%
Guggenheim
Reiterated · Buy · 2026-10-13
$1450.00
+65.10%
JP Morgan
Reiterated · Overweight · 2026-10-09
$330.00
−62.40%
Mizuho
Reiterated · Neutral · 2026-07-27
—
—
RBC Capital
Reiterated · Outperform · 2026-07-23
$1225.00
+39.50%
Morgan Stanley
Reiterated · Overweight · 2026-07-23
$817.00
−7.00%
TD Cowen
Reiterated · Buy · 2026-07-23
—
—
Oppenheimer
Reiterated · Outperform · 2026-07-23
$1338.00
+52.40%
Jefferies
Reiterated · Buy · 2026-06-11
$1185.00
+35.00%
BNP Paribas
Downgraded · Outperform → Neutral · 2026-04-27
$1190.00
+35.50%
Barclays
Reiterated · Overweight · 2026-04-23
$1250.00
+42.40%
Evercore ISI Group
Reiterated · Outperform · 2026-04-23
—
—
BMO Capital
Reiterated · Outperform · 2026-04-23
$1250.00
+42.40%
Baird
Reiterated · Outperform · 2026-04-23
—
—
Citigroup
Reiterated · Neutral · 2026-04-13
—
—
Wells Fargo
Reiterated · Overweight · 2026-03-31
$831.00
−5.40%
Rothschild & Co
Upgraded · Sell → Buy · 2026-03-09
—
—
Goldman Sachs
Reiterated · Buy · 2026-01-29
$1328.00
+51.20%
GLJ Research
Reiterated · Buy · 2026-01-12
$1087.00
+23.80%
Seaport Global
Downgraded · Buy → Neutral · 2025-12-11
$723.00
−17.70%
B of A Securities
Reiterated · Buy · 2025-12-10
—
—
UBS
Reiterated · Buy · 2025-12-10
$936.00
+6.60%
Melius Research
Upgraded · Hold → Buy · 2025-09-15
$740.00
−15.70%
HSBC
Reiterated · Hold · 2025-09-05
$255.00
−71.00%
Wolfe Research
Downgraded · Outperform → Peer Perform · 2025-06-13
—
—
Truist Securities
Reiterated · Buy · 2025-01-23
—
—
Daiwa Capital
Reiterated · Outperform → Buy · 2024-10-30
—
—
Raymond James
Downgraded · Outperform → Market Perform · 2024-10-02
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space